InCube Ventures
Venture studioSan Jose · Seed–Late Stage · 3 people tracked
Investment thesis
InCube Labs is a life sciences innovation lab, not the expected InCube Ventures firm. It identifies major unsolved clinical problems in healthcare and develops novel therapies, spinning research projects into portfolio companies for product development, clinical trials, regulatory approval, and commercialization. Focus areas span urology, gastroenterology, women's health, CNS disorders, musculoskeletal conditions, metabolic diseases, and cancer, often via implantable devices, drug-delivery combinations, and biomaterials. It collaborates with affiliated entities InCube Ventures, VentureHealth, and Modulus for funding and manufacturing support.
Source: firm website, verified Aug 2, 2026.
Team · 3 people
from the firm's website
What they invest in
from 5 of 22 portfolio companiesHealthtech ×3Biotech ×2Medical Devices ×2Deep Tech ×1Robotics ×1
HQs:United States×4
Investments · 22 tracked
founders shown can be your intro pathBiotechSan Jose, US
Talat Imran(Executive Officer, Director)Svai Sanford(Executive Officer)Mir Hashim(Executive Officer)
BoardAbraham Bassan(Director)Vasudev Bailey, M.D.(Director)
Board seatMir Imran· per SEC Form D · $60.3M raise · filed Nov 2025
HealthtechSan Jose, US
Mir Hashim(Executive Officer, Director)
BoardMir Imran(Executive Officer, Director)Andrew Farquharson(Director)
Co-investorsVHM
Neptune Medical is a medical device company developing GI endoscopy products based on its Dynamic Rigidization technology, including the FDA-cleared Pathfinder endoscope and the Triton robotic endoscopy system for colon navigation.
HealthtechMedical DevicesRoboticsSilicon Valley, US
Alex Tilson(Founder & CEO)
Co-investorsSonder CapitalMighty CapitalShangBay Capital LLC
Pioneered endocardial mapping and ablation technologies for cardiac arrhythmias; acquired by Boston Scientific.
Early-stage company developing a novel therapy for atrial fibrillation.
Developing novel treatments for gastrointestinal disorders including Crohn's disease and ulcerative colitis.
Early-stage company developing a novel transdermal therapy for iron deficiency anemia.
Developing a remote patient monitoring system to wirelessly manage patients with active implants.
Developing a gastric stimulation product platform (abiliti) for the treatment of obesity.
Early-stage company developing a novel therapy for the treatment of epilepsy.
Developed the LUNA embolization device for brain aneurysms; acquired by Covidien (then Medtronic).
Pioneered embolic protection in interventional cardiology with its Guardwire product; acquired by Medtronic.
Developed neuro-diagnostic devices including depth-of-anesthesia sensors; went public in 1996 and later acquired by Hospira.
Developing innovations for gastrointestinal disorders, including post-surgical leak resolution and bioresorbable healing devices.
Developing a disruptive technology for oral delivery of biologics.
Co-investorsSamsara BioCapital
Medical technology company developing a neuromodulation system to treat overactive bladder (OAB).
Developed mm-wave radar imaging technology for homeland security screening; acquired by L-3 Communications in 2006.
BiotechSan Francisco, US
KENNETH N. HORNE(Executive Officer, Director)KATE STUART(Executive Officer)ALYSSA PANITCH(Director)JOHN PADERI(Director)
Co-investorsMitsui Global InvestmentAlly Bridge GroupLilly Ventures
A medtech company developing a platform focused on treating neurological conditions and neurotherapeutics.
Deep TechHealthtechMedical Devices
Developed a non-surgical transurethral needle ablation therapy for benign prostatic hyperplasia; acquired by Medtronic.
Developed compact ultrasound systems using Zone Sonography imaging; acquired by Mindray.
Co-investorsApposite Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 9
IPOs and acquisitions across the tracked portfolioRani Therapeutics HoldingsNASDAQ: RANIRani TherapeuticsNASDAQ: RANICardiac Pathwaysacq. by Boston ScientificNFocusacq. by CovidienPercusurgeacq. by MedtronicPhysiometrixacq. by HospiraSafeViewacq. by L-3 CommunicationsVidamedacq. by MedtronicZonareacq. by Mindray
Portfolio news
latest coverage across their companiesNeptune Medical · fiercebiotech.com · Oct 8, 2025
Frequently asked questions
- How many investments has InCube Ventures made?
- InCube Ventures has 19 tracked investments, 7 of which have exited via acquisition or IPO.
- What stage does InCube Ventures invest at?
- InCube Ventures invests at the Seed, Series A, Late Stage stages.
- What sectors does InCube Ventures focus on?
- InCube Ventures focuses on Biotech, Healthtech, Medical Devices.
- Where is InCube Ventures located?
- InCube Ventures is headquartered in San Jose, US.
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.